TNBC: Clinical Trials

1 trial for TNBC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Enrolling by invitation 1

Follow TNBC: new trials by email Literature Review of TNBC trials Research Report on TNBC

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
HB0025 20 mg/kg plus nab-paclitaxel, HB0025 10 mg/kg plus nab-paclitaxel - TNBC
Phase 2Enrolling by invitationHuabo Biopharm Co., Ltd.602025-08-142026-01-29

Interventions

130-nm albumin-bound paclitaxel (1)

Sponsors

Huabo Biopharm Co., Ltd. (1)

Countries

China (1)